an adverse drug event than those under 65 years of age. 7 One intervention used to prevent ED visits is medication therapy management (MTM). MTM services are paid for by Medicare for select Part D beneficiaries with the aim to identify and resolve medication-related problems. 8 During MTM, the patient's medications are reconciled with known medication lists to optimize drug therapy. However, the efficacy of MTM on ED utilization among HHA patients is a gap in evidence-based policies. This study seeks to address this gap in the literature and evaluate the effectiveness of a telephonic MTM service on reducing ED utilization within a Medicare-insured HHA population. The findings from this study are particularly timely, as providers seek effective strategies during this recent period of payment and delivery system reforms to reduce preventable ED and hospital visits.
Methods
This is a post hoc analysis of data collected from a nationwide, 2-stage, randomized, controlled trial examining the effects of MTM on 60-day all-cause hospitalization. 9 Site and patient randomization was a 2-step process; first a simple random sample of 40 coordinating home health care centers with a monthly census of 20 or more admitted patients was selected among 419 care centers from a nationwide HHA (Amedisys, Inc, Baton Rouge, LA). Then, at each study site, using blocks of 7 patients, and constrained for equal allocation to study intervention or usual care groups, 28 consecutive patients newly admitted to Medicare's home health benefit were randomly assigned to either usual care or the MTM intervention using a randomization list generated by study investigators.
Recruitment and Enrollment
Enrollment began February 6, 2012, and concluded April 13, 2012. All Medicare-eligible patients admitted to the HHA from either an acute care hospital or the community were included. Patients who had any recurrent episode of homecare within the past 12 months were excluded.
On the first day of homecare, patients were informed of the study by their HHA nurse after completion of the initial in-home admissions assessment. HHA nurses were blinded to their patients' group assignment to prevent bias during the initial in-home admissions assessment. Each patient was individually followed for 60 days from the start of his or her home health care episode.
Intervention
On completion of the in-home assessment on the first day of HHA admission, the patient's medication information was faxed to the MTM contracted pharmacy organization (Curant Health; previously known as HealthStat Rx). The HHA's usual care services consisted of periodic skilled nursing care and the delivery of physical, occupational, and speech therapy within the patient's home. Patients randomized to the intervention also received pharmacist care in accordance with the core elements of MTM, as defined by the American Pharmacists Association and the National Association of Chain Drug Stores Foundation. 10 The intervention, as described previously, began approximately 3 days after in-home health admission when a pharmacy technician completed telephonic medication reconciliation with the patient and/or caregiver. 9 Then, a trained pharmacist would consult with the patient or caregiver via telephone for an average of 30 minutes to complete a scheduled comprehensive medication therapy review to identify and resolve any medication-related problems. The pharmacist constructed a personal medication record and a medication-related action plan for the patient. The action plan was a patient-centered document that assisted patients, caregivers, and the pharmacist in the resolution of identified medication-related problems. Additionally, the pharmacist would follow-up with the patient's prescriber and/or HHA staff, generally by phone or fax, for resolution of problems that could not be resolved with the patient.
For all patients receiving the telephonic MTM intervention, pharmacists provided a follow-up call on day 7 to assure resolution of medication-related problems and to identify any new medication-related problems that might arise. Additional telephone follow-up was provided as needed per the pharmacists' discretion during the first 30 days of the 60-day home health care episode. 9
Data Collection and Outcomes
The primary outcome of this study was patient-level, 60-day, all-cause ED utilization. This outcome was defined as a dichotomous variable (i.e., the patient visited the ED one or more times following the intervention or they did not). This outcome was chosen because the Centers for Medicare and Medicaid (CMS) calculate HHAs' quality, in part, by their patient's ED utilization rates. 11 Data were collected from the in-home admissions assessment, the Outcome and Assessment Information Set (OASIS-C) instrument. The OASIS-C is a standard nursing assessment required for all Medicare-certified HHAs and is utilized for most home health patients, including all Medicare patients. In addition to recording patient health-related information, the OASIS-C collects outcomes, such as ED utilization, acute care hospitalization, and discharge to the community. Each patient was followed for a total of 60 days from his or her individual home health admission.
Risk Score and Risk Stratification
A risk score for ED utilization was calculated using an existing logistic regression model that determined risk factors associated with ED utilization generated from OASIS-C variables created by CMS and is used in generating HHA quality reports, including public reports on Medicare's Home Health Compare website. 12 These data for risk score calculation was taken from the initial home health OASIS-C assessment, completed by the home health nurse at the beginning of home health admission. The CMS model identifies 83 risk factors associated with ED utilization (R 2 = 0.09 C-stat = 0.72). 12 A risk score was developed using the regression coefficients from each statistically significant variable (P < .05) included in the model. The regression coefficients were summed to result in a risk score. Patients were then stratified into quartiles based on their calculated risk of ED utilization, with quartile 1 being the highest risk and quartile 4 being lowest risk.
Analysis
As this is a secondary analysis, the original sample size was powered to detect a moderate effect of the intervention on 60-day all-cause hospitalization, not ED utilization. 9 This secondary analysis was approved by the Purdue University Institutional Review Board. As the primary outcome was defined as a dichotomous variable, once an ED visit occurred, any additional ED visits were censored.
A multivariable logistic regression model was fit using generalized estimating equations (GEE) to examine the effects of the MTM intervention on the probability of 60-day all-cause ED utilization. A GEE model was used to control for variation attributable to home health care center (cluster). The quartile of ED risk was included in the model as a categorical variable. Variables deemed important to the intervention and outcome were used in the model irrespective of their significance, including the patient's total number of medications, age, ability to use a telephone, and detection of any medication-related problems during the nurses' initial in-home admission assessment.
Results
A total of 961 patients from a targeted goal of 1120 patients were randomized to control or intervention. Operational and budgetary constraints during the original trial prevented enrollment of the targeted sample size. Twenty-three of the 40 care centers reached their enrollment goals. There were 59 patients in the intervention group who could not be reached by telephone for the MTM intervention. One intervention patient and 6 usual care patients were lost to followup. The primary outcome variable was unavailable in 188 intervention patients and 121 usual care patients, providing 297 intervention patients and 359 usual care patients included in this analysis (Figure 1 ).
There were no significant differences in the characteristics of patients at baseline between the intervention and usual care groups (Table 1 ). In general, patients in this study were 73 (±13) years old and taking 14 (±9) total medications, with an average of 1.4 comorbid conditions. 10 A total of 162 patients visited the ED within 60 days of HHA admission, 72 (24.4%) from the intervention group and 90 (25.1%) from the usual care group. Overall, the intervention did not significantly reduce ED utilization for the entire study population (adjusted odds ratio = 1.11; 95% confidence interval = 0.79-1.57). However, ED utilization among intervention patients in the lowest risk-quartile (quartile 4) was statistically lower than among usual care patients in the lowest risk-quartile (adjusted odds ratio = 2.52; 95% confidence interval = 1.15-5.49; P = .02; Table 2 ).
Discussion
In this post hoc study, telephonic MTM did not reduce the overall odds of utilizing an ED at least once within the first 60 days following the intervention in a Medicare HHA population. However, the intervention significantly lowered ED utilization in patients who were deemed low-risk. These findings align with the hospitalization outcomes observed in the original study. 9 There are several potential explanations for our findings. Medicare patients who receive services from HHAs are a sick population. Consequently, these patients may rely less on self-management and more on their home health nurse and other caregivers. In other words, the overall patient population may not rely as heavily on their own self-initiative to administer medications correctly and timely, whereas those who are less ill are more likely to manage their own medications. Similarly, patients who are more mobile and are more independent in their activities of daily living scored lower on their risk of ED utilization. As a result, the MTM intervention may have alerted these patients to situations in which they had control to act upon physically. Most likely, patients who were lowest risk could be more abled, and directly utilize tools from the intervention to improve their care. Alternatively, sicker patients with less independence may have obtained knowledge from the intervention, but did not have the required functionality to act on that knowledge. Moreover, higher risk patients' caregivers may not have been equipped with the tools needed to improve outcomes. In the future, telephonic MTM interventions may be more successful for higher risk patients if delivered congruently with both the patient and his/her caregivers or focus more on the service on caregiver needs for medication management.
Another explanation for these findings may be that patients in risk quartiles 1 to 3 were in poor health and may require emergent care regardless of their medication adherence or presence of a medication-related problem. We could surmise that because the study population received home health services, that those who were most sick (and thus in the highest risk quartiles for ED utilization) may have utilized the ED necessarily.
Evidence does exist for reduced ED utilization when pharmacists are involved in discharge services, but not for home health patients. 13 Reduced ED utilization may occur because pharmacists are able to intervene on problems that might have otherwise escalated into necessitating emergency care.
In relation with our findings, an analysis conducted by Welch et al found that telephonic MTM was associated with fewer deaths but increased hospitalization and no change in ED utilization among "home-based" Medicare Part D patients. It is unclear whether these patients were receiving HHA services or were self-and/or payer-described as home bound. 14 This could indicate that MTM peridischarge may propagate resource utilization as health care professionals are able to detect and intervene early before problems escalate.
Our study has several limitations. First, the date of ED utilization was not documented, rather only the occurrence of an ED visit during the 60-day period was available in the OASIS-C. While there was no overall difference among usual care and intervention utilization rates, time to event analysis could not be completed. Additionally, reasons for ED utilization were not captured, so it is unknown if ED utilization was due to medical conditions within the clinical practice scope of the MTM pharmacist. Last, there were more patients in the intervention group admitted from the community setting than the control group; patients admitted directly from the community may have been more healthy than their peers admitted from long-term care.
Furthermore, the original study was powered for hospitalizations as the primary outcome, not ED visits. Moreover, we did not meet our enrollment target in the original study and excluded 59 enrolled patients from the analysis who were unable to be reached for the intervention, further limiting the power of the study. Therefore, it is possible that enrolling more patients would have been necessary for us to observe a significant reduction in ED utilization among patients in the higher risk quartiles.
Last, patients were discharged from the hospital on average 3 days before their first telephonic conversation with the pharmacist. The effect size seen may have been larger if pharmacists were able to speak with the patient on the day of hospital discharge or within 24 hours of discharge.
Conclusion
Telephonic MTM may further decrease ED utilization in HHA patients who are at low risk. However, a more robust, in-person, or tele-health MTM solution and/or improved patient targeting may potentially be needed to accommodate the advanced needs of home health patients with more advanced conditions. Future research is needed to optimize pharmacist-delivered peridischarge services so that interventions may be targeted to patient or caregiver characteristics.
